Results 91 to 100 of about 8,298 (167)

Novel <i>Pfk13</i> and <i>Pfubp1</i> genotypes in African <i>Plasmodium falciparum</i> isolates exhibiting reduced susceptibility to the antimalarials artemisinin and lumefantrine. [PDF]

mBio
Pratt S, van Schalkwyk DA, Stewart L, Hocke EF, Mannan S, Berry C, Muwanguzi-Karugaba J, Nolder D, Rogers C, Chiodini PL, Henrici RC, Moss S, Billows N, Phelan J, Clark TG, Campino S, Sutherland CJ.   +16 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Knowledge, attitudes, and practices of Sudanese medical professionals regarding the 2023 Sudan malaria treatment protocol: a cross-sectional study. [PDF]

Malar J
Yousif YOE, Kheerallah RMI, Ahmed MKM, Bakheit KMA, Abdelrahman AOO, Elobied HES, Ali SBH, Ismail SAE, Elshaikh SME, Yousif TAA, Ibrahim AEM, Hassan AEA, Alhag MAA, Adam FRI, Elhag OEY, Eljack MMF.   +15 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine combination for the treatment of uncomplicated Plasmodium falciparum malaria after 16 years of its introduction into Ghana's antimalarial medicines policy. [PDF]

Malar J
Abuaku B, Boateng P, Duah-Quashie NO, Peprah NY, Asamoah A, Matrevi SA, Idun-Acquah J, Amoako EO, Baafi E, Gyekye E, Amankrah-Yeboah N, Logonia B, Bruku S, Tandoh K, Quashie N, Owusu-Antwi F, Koram KA, Abiwu PH, Malm KL.   +18 more
europepmc   +1 more source

Resurgence of Malaria in Ethiopia. [PDF]

JAMA
Assefa A, Brhane BG, Gerdes Gyuricza I, Sime H, Belachew M, Hailu Dangisso M, Tollera G, Bailey JA, Juliano JJ, Fola AA, Tasew G, Parr JB, Malaria Resurgence Investigation Group.   +12 more
europepmc   +1 more source

Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood. [PDF]

Clin Infect Dis
Saito M, Gilder ME, Carrara VI, Archusuksan L, Eh H, Eh N, Ner M, Win AK, Niwetphongprai L, Koesukwiwat U, Tarning J, White NJ, Nosten F, McGready R.   +13 more
europepmc   +1 more source

Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV. [PDF]

Clin Pharmacol Ther
Kajubi R, Koire M, Whalen ME, Orukan F, Okiring J, Marzan F, Richards K, Lier AJ, Goodwin J, Colt M, Pham X, He S, Chu DHT, Opira B, Kisitu GP, Sekabira R, Kekitiinwa A, Huynh D, Khoury M, Gallison K, Fotaki N, Mwima MW, Kamya MR, Aweeka FT, Parikh S, Huang L, Mwebaza N.   +26 more
europepmc   +1 more source

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria among children 6-59 months in three sentinel sites of Sierra Leone, 2021-2022. [PDF]

Malar J
Cavros I, Abanyie F, Kamara ARY, Chalobah F, Fofana N, Ahmed J, Larbi K, Kennedy C, Horton B, Bajic M, Richardson M, Matlock B, McCaffery J, Kanu S, Schnabel D, Labor TSA, Cash S, Plucinski M, Komeh JP, Sillah-Kanu M.   +19 more
europepmc   +1 more source

Gaps in knowledge and use of artemether-lumefantrine among university students in Southwestern Nigeria: A cross-sectional study. [PDF]

PLoS One
Orok E, Olumoko O, Ekada I, Oladunni A.
europepmc   +1 more source

Efficacy of artemether lumefantrine vs chloroquine for the treatment of Plasmodium Vivax infection in Pakistan. [PDF]

Sci Rep
Khan S, Muqtadir J, Abbas SA, Ayoob K, Wahab A, Zaidi SHM, Das B, Bhatti S, Vohra EA.   +8 more
europepmc   +1 more source